MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

KKW To, CWS Tong, M Wu… - World Journal of …, 2018 - pmc.ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are small, single-stranded, noncoding RNAs that can post-
transcriptionally regulate the expression of various oncogenes and tumor suppressor genes …

Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review

JE Ryan, SK Warrier, AC Lynch, RG Ramsay… - Colorectal …, 2016 - Wiley Online Library
Aim Approximately 20% of patients treated with neoadjuvant chemoradiotherapy (nCRT) for
locally advanced rectal cancer achieve a pathological complete response (p CR) while the …

A microRNA-21–mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis

RY Kim, KP Sunkara, KR Bracke, AG Jarnicki… - Science translational …, 2021 - science.org
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and
death worldwide. Inhalation of cigarette smoke (CS) is the major cause in developed …

Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models

M Li, Q **ao, N Venkatachalam… - Therapeutic …, 2022 - journals.sagepub.com
Colorectal cancer (CRC) is a major contributor to cancer-associated morbidity worldwide
and over one-third of CRC is located in the rectum. Neoadjuvant chemoradiotherapy (nCRT) …

[HTML][HTML] MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24

Z Hu, Y Zhao, Y Mang, J Zhu, L Yu, L Li, J Ran - Life sciences, 2023 - Elsevier
Objective To validate the mechanism by which miR-21-5p mediates autophagy in drug-
resistant cells in hepatocellular carcinoma (HCC), aggravating sorafenib resistance and …

MicroRNAs and colorectal cancer chemoresistance: New solution for old problem

M Vaghari-Tabari, M Majidinia, S Moein, D Qujeq… - Life Sciences, 2020 - Elsevier
Background Colorectal cancer (CRC) is one of the most common gastrointestinal
malignancies with a significant mortality rate. Despite the great advances in cancer …

MicroRNAs as regulators, biomarkers and therapeutic targets in the drug resistance of colorectal cancer

T **e, M Huang, Y Wang, L Wang, C Chen… - Cellular Physiology and …, 2016 - karger.com
Chemotherapy and targeted therapy are the main options for andvanced colorectal cancer
(CRC). However, resistance to these therapies is a major challenge in the clinic …

Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively

J Chen, Y **a, X Sui, Q Peng, T Zhang, J Li… - Oncotarget, 2018 - pmc.ncbi.nlm.nih.gov
New anticancer agents with lower toxicity have been always urged because of drug
resistance associated with overused chemotherapy agents. In this study, steviol, a colonic …

miR-21, an oncogenic target miRNA for cancer therapy: molecular mechanisms and recent advancements in chemo and radio-resistance

S Javanmardi, M Reza Aghamaali… - Current gene …, 2016 - ingentaconnect.com
In the past decade, miRNAs have been extensively attracted the scientist's attentions as
tumor suppressors or oncogenes that have been implicated in tumor progression …

MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.

L Tao, YQ Wu, SP Zhang - Neoplasma, 2019 - search.ebscohost.com
Abstract MiR-21-5p has been identified as an oncogene to enhance human tumor
progression. Here, we explored the mechanism by which miR-21-5p regulated progression …